Monoclonal Antibodies vs. Vaccines vs. COVID-19: What to Know
1 min readInfectious Illnesses Society of America: “Monoclonal Antibodies.”

The New England Journal of Medicine: “Subcutaneous REGEN-COV Antibody Mix to Avert Covid-19.”
William Fales, MD, clinical director, Michigan Department of Wellness and Human Products and services, Division of EMS and Trauma.
Lindsay Petty, MD, infectious disorder medical doctor, College of Michigan.
Eli Lilly: “Emergency Use Authorization (EUA) for the Treatment of COVID-19.”
Fda: “Emergency Use Authorization (EUA) for bamlanivimab 700mg IV Heart for Drug Evaluation and Study (CDER) Memorandum on Simple fact Sheet Update.”
David Wohl, MD, infectious illness qualified, University of North Carolina.
CDC: “People with Specified Healthcare Conditions.”
Regeneron: “REGEN-COV for COVID-19: Emergency Use Authorization (EUA).”
